Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

A relapsing case of pulmonary-renal syndrome after a sequential rise in MPO-ANCA and anti-GBM antibodies.

Hoshino A, Sakairi T, Kayakabe K, Baba M, Ando M, Kimura H, Motohashi R, Nojima Y, Hiromura K.

CEN Case Rep. 2019 Aug;8(3):221-225. doi: 10.1007/s13730-019-00397-1. Epub 2019 Apr 3.

2.

Enhancement of HGF-induced tubulogenesis by endothelial cell-derived GDNF.

Nakasatomi M, Takahashi S, Sakairi T, Ikeuchi H, Kaneko Y, Hiromura K, Nojima Y, Maeshima A.

PLoS One. 2019 Mar 7;14(3):e0212991. doi: 10.1371/journal.pone.0212991. eCollection 2019.

3.

Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis.

Kitagawa A, Tsuboi N, Yokoe Y, Katsuno T, Ikeuchi H, Kajiyama H, Endo N, Sawa Y, Suwa J, Sugiyama Y, Hachiya A, Mimura T, Hiromura K, Maruyama S.

Kidney Int. 2019 Mar;95(3):680-692. doi: 10.1016/j.kint.2018.10.025. Epub 2019 Jan 31.

PMID:
30712924
4.

Hypertrophic pachymeningitis associated with antineutrophil cytoplasmic antibody-associated vasculitis: a case series of 15 patients.

Sakairi T, Sakurai N, Nakasatomi M, Ikeuchi H, Kaneko Y, Maeshima A, Nojima Y, Hiromura K.

Scand J Rheumatol. 2019 May;48(3):218-224. doi: 10.1080/03009742.2018.1498916. Epub 2018 Nov 5.

PMID:
30394816
5.

Effects of Neutralizing Antibody Production on AAV-PHP.B-Mediated Transduction of the Mouse Central Nervous System.

Shinohara Y, Konno A, Nitta K, Matsuzaki Y, Yasui H, Suwa J, Hiromura K, Hirai H.

Mol Neurobiol. 2019 Jun;56(6):4203-4214. doi: 10.1007/s12035-018-1366-4. Epub 2018 Oct 5.

PMID:
30291583
6.

Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review.

Ikeuchi H, Koinuma K, Nakasatomi M, Sakairi T, Kaneko Y, Maeshima A, Yamazaki Y, Okamoto H, Mimura T, Mochida S, Nojima Y, Hiromura K.

Case Rep Rheumatol. 2018 Jul 26;2018:6873276. doi: 10.1155/2018/6873276. eCollection 2018.

7.

The Analysis of Renal Infiltrating Cells in Acute Tubulointerstitial Nephritis Induced by Anti-PD-1 Antibodies: A Case Report and Review of the Literature.

Tabei A, Watanabe M, Ikeuchi H, Nakasatomi M, Sakairi T, Kaneko Y, Maeshima A, Kaira K, Hirato J, Nojima Y, Hiromura K.

Intern Med. 2018 Nov 1;57(21):3135-3139. doi: 10.2169/internalmedicine.0444-17. Epub 2018 Jun 6. Review.

8.

TGF-β1 alters DNA methylation levels in promoter and enhancer regions of the WT1 gene in human podocytes.

Hamatani H, Sakairi T, Ikeuchi H, Kaneko Y, Maeshima A, Nojima Y, Hiromura K.

Nephrology (Carlton). 2019 May;24(5):575-584. doi: 10.1111/nep.13411.

PMID:
29851165
9.

Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.

Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.

Clin Exp Nephrol. 2018 Dec;22(6):1266-1280. doi: 10.1007/s10157-018-1579-x. Epub 2018 Apr 20.

PMID:
29679356
10.

Identification of Urinary Activin A as a Novel Biomarker Reflecting the Severity of Acute Kidney Injury.

Takahashi S, Nakasatomi M, Takei Y, Ikeuchi H, Sakairi T, Kaneko Y, Hiromura K, Nojima Y, Maeshima A.

Sci Rep. 2018 Mar 26;8(1):5176. doi: 10.1038/s41598-018-23564-3.

11.

The correlation of urinary podocytes and podocalyxin with histological features of lupus nephritis.

Ikuma D, Hiromura K, Kajiyama H, Suwa J, Ikeuchi H, Sakairi T, Kaneko Y, Maeshima A, Kurosawa H, Hirayama Y, Yokota K, Araki Y, Sato K, Asanuma YF, Akiyama Y, Hara M, Nojima Y, Mimura T.

Lupus. 2018 Mar;27(3):484-493. doi: 10.1177/0961203317734918. Epub 2017 Oct 19.

PMID:
29050536
12.

Five patients who died during treatment for adult Still's disease.

Motohashi R, Uchiyama K, Ikeuchi H, Nojima Y, Hiromura K.

Mod Rheumatol. 2018 Mar;28(2):381-382. doi: 10.1080/14397595.2017.1351048. Epub 2017 Jul 25. No abstract available.

PMID:
28741971
13.

Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3.

Ito A, Okada Y, Hashita T, Aomori T, Hiromura K, Nojima Y, Nakamura T, Araki T, Yamamoto K.

Biochem Genet. 2017 Jun;55(3):268-277. doi: 10.1007/s10528-017-9795-8. Epub 2017 Mar 21.

14.

Involvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice.

Kadiombo AT, Maeshima A, Kayakabe K, Ikeuchi H, Sakairi T, Kaneko Y, Hiromura K, Nojima Y.

Am J Physiol Renal Physiol. 2017 Feb 1;312(2):F297-F304. doi: 10.1152/ajprenal.00191.2016. Epub 2016 Nov 23.

15.

Clinical and histological features of lupus nephritis in Japan: A cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR).

Hiromura K, Ikeuchi H, Kayakabe K, Sugiyama H, Nagata M, Sato H, Yokoyama H, Nojima Y.

Nephrology (Carlton). 2017 Nov;22(11):885-891. doi: 10.1111/nep.12863.

PMID:
27461874
16.

Renal outcomes in mixed proliferative and membranous lupus nephritis (Class III/IV + V): A long-term observational study.

Ikeuchi H, Hiromura K, Kayakabe K, Tshilela KA, Uchiyama K, Hamatani H, Sakairi T, Kaneko Y, Maeshima A, Nojima Y.

Mod Rheumatol. 2016 Nov;26(6):908-913. doi: 10.3109/14397595.2016.1158896. Epub 2016 Apr 26.

PMID:
27115200
17.

Histological findings in the spleen affected by adult-onset Still's disease: a report of three cases.

Sakairi T, Hiromura K, Kaneko Y, Maeshima A, Hirato J, Nojima Y.

Clin Exp Rheumatol. 2016 May-Jun;34(3):566-7. Epub 2016 Feb 2. No abstract available.

PMID:
26841850
18.

Successful treatment of severe crescentic lupus nephritis by multi-target therapy using tacrolimus and mycophenolate mofetil.

Mochizuki K, Kayakabe K, Hiromura K, Ando M, Sakurai N, Ikeuchi H, Sakairi T, Kaneko Y, Maeshima A, Nojima Y.

CEN Case Rep. 2015 Nov;4(2):126-130. doi: 10.1007/s13730-014-0151-0. Epub 2014 Oct 12.

19.

[Management of Cervical Cancer Stage I B during Pregnancy].

Suzuki K, Shinbo A, Hando M, Hiromura K, Mizuno K.

Gan To Kagaku Ryoho. 2015 Sep;42(9):1123-5. Japanese.

PMID:
26469174
20.

A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan.

Hara R, Miyazawa H, Nishimura K, Momoi T, Nozawa T, Kikuchi M, Sakurai N, Kizawa T, Shimamura S, Yasuda S, Hiromura K, Sada KE, Kawaguchi Y, Tamura N, Takei S, Takasaki Y, Atsumi T, Mori M.

Mod Rheumatol. 2015;25(6):858-64. doi: 10.3109/14397595.2015.1077555. Epub 2015 Sep 7.

PMID:
26215483
21.

Novel approach for the detection of tubular cell migration into the interstitium during renal fibrosis in rats.

Nakasatomi M, Maeshima A, Mishima K, Ikeuchi H, Sakairi T, Kaneko Y, Hiromura K, Nojima Y.

Fibrogenesis Tissue Repair. 2015 Jul 10;8:12. doi: 10.1186/s13069-015-0030-0. eCollection 2015.

22.

Glomerular cytokine expression in murine lupus nephritis.

Tshilela KA, Ikeuchi H, Matsumoto T, Kuroiwa T, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Hiromura K, Nojima Y.

Clin Exp Nephrol. 2016 Feb;20(1):23-9. doi: 10.1007/s10157-015-1123-1. Epub 2015 May 19.

PMID:
25985839
23.

Surveillance for the use of mycophenolate mofetil for adult patients with lupus nephritis in Japan.

Yasuda S, Atsumi T, Shimamura S, Ono K, Hiromura K, Sada K, Mori M, Takei S, Kawaguchi Y, Tamura N, Takasaki Y.

Mod Rheumatol. 2015;25(6):854-7. doi: 10.3109/14397595.2015.1031444. Epub 2015 Apr 30.

PMID:
25800636
24.

Two cases of ulcerative colitis developing in rheumatoid arthritis patients during abatacept therapy.

Motohashi R, Ikeuchi H, Hiromura K, Ohishi Y, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Nojima Y.

Scand J Gastroenterol. 2014 Oct;49(10):1270-1. doi: 10.3109/00365521.2014.946087. Epub 2014 Aug 13. No abstract available.

PMID:
25115461
25.

Expression of a novel stress-inducible protein, sestrin 2, in rat glomerular parietal epithelial cells.

Hamatani H, Hiromura K, Sakairi T, Takahashi S, Watanabe M, Maeshima A, Ohse T, Pippin JW, Shankland SJ, Nojima Y.

Am J Physiol Renal Physiol. 2014 Sep 15;307(6):F708-17. doi: 10.1152/ajprenal.00625.2013. Epub 2014 Jul 23.

26.

[Lupus nephritis and nephrotic syndrome: diagnosis and treatment].

Hiromura K, Ikeuchi H, Kayakabe K, Nojima Y.

Nihon Jinzo Gakkai Shi. 2014;56(4):510-7. Review. Japanese. No abstract available.

PMID:
24956883
27.

Follistatin, an activin antagonist, ameliorates renal interstitial fibrosis in a rat model of unilateral ureteral obstruction.

Maeshima A, Mishima K, Yamashita S, Nakasatomi M, Miya M, Sakurai N, Sakairi T, Ikeuchi H, Hiromura K, Hasegawa Y, Kojima I, Nojima Y.

Biomed Res Int. 2014;2014:376191. doi: 10.1155/2014/376191. Epub 2014 May 5.

28.

A case of ANCA-negative renal small-vessel vasculitis with tubulointerstitial infiltration of IgG4-positive plasma cells.

Sakairi T, Okabe S, Hiromura K, Motegi S, Sakurai N, Ikeuchi H, Kaneko Y, Maeshima A, Hirato J, Nojima Y.

Mod Rheumatol. 2016 Sep;26(5):780-3. doi: 10.3109/14397595.2014.915510. Epub 2014 May 20.

PMID:
24842479
30.

Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.

Ikeuchi H, Hiromura K, Takahashi S, Mishima K, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Kuroiwa T, Nojima Y.

Mod Rheumatol. 2014 Jul;24(4):618-25. doi: 10.3109/14397595.2013.844397. Epub 2013 Oct 21.

PMID:
24252014
31.

SIRPα signaling regulates podocyte structure and function.

Takahashi S, Tomioka M, Hiromura K, Sakairi T, Hamatani H, Watanabe M, Ikeuchi H, Kaneko Y, Maeshima A, Aoki T, Ohnishi H, Matozaki T, Nojima Y.

Am J Physiol Renal Physiol. 2013 Sep 15;305(6):F861-70. doi: 10.1152/ajprenal.00597.2012. Epub 2013 Jul 10.

32.

Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency.

Takahashi S, Hiromura K, Tsukida M, Ohishi Y, Hamatani H, Sakurai N, Sakairi T, Ikeuchi H, Kaneko Y, Maeshima A, Kuroiwa T, Yokoo H, Aoki T, Nagata M, Nojima Y.

J Am Soc Nephrol. 2013 Jul;24(8):1305-12. doi: 10.1681/ASN.2012090913. Epub 2013 Apr 25.

33.

[Granulosa cell tumor of the ovary - analysis of 15 cases in a single institution].

Hiromura K, Ban M, Maseki Y, Ikeda S, Onishi K, Yokoi A, Nakayama M, Shinbo A, Hando M, Miyazaki K, Kihira K, Ando T, Mizuno K, Furuhashi M, Fujino M, Ito M.

Gan To Kagaku Ryoho. 2013 Feb;40(2):203-7. Japanese.

PMID:
23411956
34.

Involvement of N-type Ca(2+) channels in the fibrotic process of the kidney in rats.

Mishima K, Maeshima A, Miya M, Sakurai N, Ikeuchi H, Hiromura K, Nojima Y.

Am J Physiol Renal Physiol. 2013 Mar 15;304(6):F665-73. doi: 10.1152/ajprenal.00561.2012. Epub 2013 Jan 16.

35.

Effect of genetic polymorphisms on effectiveness of low-dose azathioprine in Japanese patients with systemic lupus erythematosus.

Nagamine A, Takenaka M, Aomori T, Okada Y, Hiromura K, Nojima Y, Araki T, Nakamura T, Yamamoto K.

Am J Health Syst Pharm. 2012 Dec 1;69(23):2072-8. doi: 10.2146/ajhp120179.

PMID:
23172266
36.

Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR).

Yokoyama H, Sugiyama H, Sato H, Taguchi T, Nagata M, Matsuo S, Makino H, Watanabe T, Saito T, Kiyohara Y, Nishi S, Iida H, Morozumi K, Fukatsu A, Sasaki T, Tsuruya K, Kohda Y, Higuchi M, Kiyomoto H, Goto S, Hattori M, Hataya H, Kagami S, Yoshikawa N, Fukasawa Y, Ueda Y, Kitamura H, Shimizu A, Oka K, Nakagawa N, Ito T, Uchida S, Furuichi K, Nakaya I, Umemura S, Hiromura K, Yoshimura M, Hirawa N, Shigematsu T, Fukagawa M, Hiramatsu M, Terada Y, Uemura O, Kawata T, Matsunaga A, Kuroki A, Mori Y, Mitsuiki K, Yoshida H; Committee for the Standardization of Renal Pathological Diagnosis and for Renal Biopsy and Disease Registry of the Japanese Society of Nephrology, and the Progressive Renal Disease Research of the Ministry of Health, Labour and Welfare of Japan.

Clin Exp Nephrol. 2012 Dec;16(6):903-20. doi: 10.1007/s10157-012-0673-8. Epub 2012 Oct 11.

PMID:
23053590
37.

Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents.

Fujita Y, Araki T, Okada Y, Aomori T, Shimizu R, Tomizawa T, Hiromura K, Nojima Y, Nakamura T, Yamamoto K.

J Clin Pharm Ther. 2013 Feb;38(1):74-6. doi: 10.1111/jcpt.12004. Epub 2012 Sep 12.

PMID:
22971159
38.

[Case report: posterior reversible encephalopathy syndrome and scleroderma renal crisis developed in a patient with overlap syndrome after treatment with high-dose steroids and tacrolimus].

Matsui A, Ikeuchi H, Shimizu A, Takahashi S, Mishima K, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Hiromura K, Nojima Y.

Nihon Naika Gakkai Zasshi. 2012 Jul 10;101(7):2051-4. Japanese. No abstract available.

PMID:
22897011
39.

Interleukin-1β measurement in stimulated whole blood cultures is useful to predict response to anti-TNF therapies in rheumatoid arthritis.

Kayakabe K, Kuroiwa T, Sakurai N, Ikeuchi H, Kadiombo AT, Sakairi T, Kaneko Y, Maeshima A, Hiromura K, Nojima Y.

Rheumatology (Oxford). 2012 Sep;51(9):1639-43. doi: 10.1093/rheumatology/kes094. Epub 2012 May 16.

PMID:
22596214
40.

Interleukin-6 promotes destabilized angiogenesis by modulating angiopoietin expression in rheumatoid arthritis.

Kayakabe K, Kuroiwa T, Sakurai N, Ikeuchi H, Kadiombo AT, Sakairi T, Matsumoto T, Maeshima A, Hiromura K, Nojima Y.

Rheumatology (Oxford). 2012 Sep;51(9):1571-9. doi: 10.1093/rheumatology/kes093. Epub 2012 May 16.

PMID:
22596210
41.

Efficacy of tocilizumab, a humanized neutralizing antibody against interleukin-6 receptor, in progressive renal injury associated with Castleman's disease.

Maeshima A, Nakasatomi M, Henmi D, Yamashita S, Kaneko Y, Kuroiwa T, Hiromura K, Nojima Y.

CEN Case Rep. 2012 May;1(1):7-11. doi: 10.1007/s13730-012-0004-7. Epub 2012 Mar 17.

42.

Dendritic cell-specific ablation of the protein tyrosine phosphatase Shp1 promotes Th1 cell differentiation and induces autoimmunity.

Kaneko T, Saito Y, Kotani T, Okazawa H, Iwamura H, Sato-Hashimoto M, Kanazawa Y, Takahashi S, Hiromura K, Kusakari S, Kaneko Y, Murata Y, Ohnishi H, Nojima Y, Takagishi K, Matozaki T.

J Immunol. 2012 Jun 1;188(11):5397-407. doi: 10.4049/jimmunol.1103210. Epub 2012 Apr 25.

43.

Age-related decline in label-retaining tubular cells: implication for reduced regenerative capacity after injury in the aging kidney.

Miya M, Maeshima A, Mishima K, Sakurai N, Ikeuchi H, Kuroiwa T, Hiromura K, Nojima Y.

Am J Physiol Renal Physiol. 2012 Mar 15;302(6):F694-702. doi: 10.1152/ajprenal.00249.2011. Epub 2011 Dec 14.

44.

Hydronephrosis caused by a relapse of granulomatosis with polyangiitis (Wegener's).

Umemoto A, Ikeuchi H, Hiromura K, Hamatani H, Sakurai N, Sakairi T, Matsumoto T, Maeshima A, Kuroiwa T, Nojima Y.

Mod Rheumatol. 2012 Aug;22(4):616-20. doi: 10.1007/s10165-011-0554-0. Epub 2011 Nov 9.

PMID:
22065104
45.

[Pneumocystis pneumonia developed in two patients with rheumatoid arthritis during treatment of adalimumab].

Ikeuchi H, Umemoto A, Tsukida M, Sakurai N, Maeshima A, Kuroiwa T, Hiromura K, Nojima Y.

Nihon Rinsho Meneki Gakkai Kaishi. 2011;34(5):420-5. Japanese.

46.

[Glossitis by mixed infection of cytomegalovirus and herpes simplex virus during therapy for pure red cell aplasia complicated with Good syndrome].

Koya H, Yokohama A, Miura A, Hoshino T, Mitsui T, Koiso H, Saitoh T, Uchiumi H, Handa H, Hirato J, Hiromura K, Karasawa M, Murakami H, Tsukamoto N, Nojima Y.

Rinsho Ketsueki. 2011 Aug;52(8):708-12. Japanese.

PMID:
21897079
47.

Enhancement of in vitro human tubulogenesis by endothelial cell-derived factors: implications for in vivo tubular regeneration after injury.

Miya M, Maeshima A, Mishima K, Sakurai N, Ikeuchi H, Kuroiwa T, Hiromura K, Yokoo H, Nojima Y.

Am J Physiol Renal Physiol. 2011 Aug;301(2):F387-95. doi: 10.1152/ajprenal.00619.2010. Epub 2011 May 11.

48.

Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis.

Takahashi S, Hiromura K, Sakurai N, Matsumoto T, Ikeuchi H, Maeshima A, Kaneko Y, Kuroiwa T, Nojima Y.

Mod Rheumatol. 2011 Jun;21(3):282-9. doi: 10.1007/s10165-010-0398-z. Epub 2010 Dec 29.

PMID:
21188448
49.

Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo.

Sakairi T, Hiromura K, Takahashi S, Hamatani H, Takeuchi S, Tomioka M, Maeshima A, Kuroiwa T, Nojima Y.

Nephrology (Carlton). 2011 Jan;16(1):76-86. doi: 10.1111/j.1440-1797.2010.01367.x.

PMID:
21175982
50.

Successful treatment of lipoprotein glomerulopathy in a daughter and a mother using niceritrol.

Hamatani H, Hiromura K, Kobatake K, Yoshida H, Kobayashi S, Yoneda N, Kayakabe K, Matsumoto T, Kuroiwa T, Ueki K, Nojima Y.

Clin Exp Nephrol. 2010 Dec;14(6):619-24. doi: 10.1007/s10157-010-0333-9. Epub 2010 Sep 15.

PMID:
20842518

Supplemental Content

Loading ...
Support Center